Membranous Nephropathy
📧 Sign up to get email alerts when something new happens for Membranous Nephropathy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-06-03Clinical Trial Update: A Study to Examine the Efficacy and Safety of Zanubrutinib Given to Adults With Primary Membranous Nephropathy [Phase 2, Phase 3]
A Phase 2/3 clinical trial evaluating the efficacy and safety of zanubrutinib in adults with primary membranous nephropathy is active but no…
-
CLINICAL_TRIALS trial_result · 2026-04-22Clinical Trial Update: Study of ALXN1920 in Adult Participants With Primary Membranous Nephropathy (PMN) [Phase 2]
A Phase 2 clinical trial of ALXN1920 in adults with primary membranous nephropathy is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-04-16Clinical Trial Update: Efficacy and Safety of CD19 CAR-γδ T Cells in the Treatment of Relapsed/Refractory Autoimmune Nephropathy [EARLY_Phase 1]
Clinical trial update for a Phase 1 study of CD19 CAR-γδ T cells in relapsed/refractory autoimmune nephropathy, targeting membranous nephrop…
-
CLINICAL_TRIALS trial_result · 2026-04-08Clinical Trial Update: SLIT ABS: Study on Patients With Autoimmune Podocytopathy [NA]
This clinical trial update indicates the SLIT ABS study for autoimmune podocytopathy is currently recruiting, sponsored by Meyer Children's …
-
CLINICAL_TRIALS trial_result · 2026-03-30Clinical Trial Update: Safety Study of IgAN, LN, MN, & C3 Glomerulopathy Including Dense Deposit Disease Treated With OMS721 [Phase 2]
Omeros' Phase 2 safety study of OMS721 in immunoglobulin A nephropathy, lupus nephritis, membranous nephropathy, and C3 glomerulopathy inclu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-03-24Clinical Trial Update: In Vitro Immunomodulation in Membranous Nephropathy Relapses [NA]
A clinical trial investigating in vitro immunomodulation in membranous nephropathy relapses has completed.
-
CLINICAL_TRIALS trial_result · 2026-03-20Clinical Trial Update: Effect of B-cell Depleting Therapies on PLA2R-specific B Cells in Patients With Membranous Nephropathy [NA]
A completed clinical trial update examining how B-cell depleting therapies affect PLA2R-specific B cells in patients with membranous nephrop…
-
CLINICAL_TRIALS trial_result · 2026-03-03Clinical Trial Update: Analysis of T- and B-Cell Subpopulations in Membranous Nephropathy
Completed clinical trial analyzing T- and B-cell subpopulations in membranous nephropathy, including PLA2R-induced and THSD7A-induced subtyp…
-
CLINICAL_TRIALS trial_result · 2026-02-12Clinical Trial Update: Efficacy and Safety of VB119 in Subjects With Membranous Nephropathy [Phase 1, Phase 2]
The update reports on the efficacy and safety of VB119 in membranous nephropathy across Phase 1/2, but the trial was terminated.
-
CLINICAL_TRIALS trial_result · 2025-12-24Clinical Trial Update: Safety and Efficacy of CD19 Chimeric Antigen Receptor T-Cell (CAR-T) in the Treatment of Refractory Membranous Nephropathy [Phase 1]
Phase 1 clinical trial evaluating safety and efficacy of CD19 CAR-T cell therapy for refractory membranous nephropathy is currently recruiti…
-
CLINICAL_TRIALS trial_result · 2025-11-17Clinical Trial Update: A Phase Ib/ Ⅱ Clinical Study of MIL62 in Primary Membranous Nephropathy [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating MIL62 in primary membranous nephropathy has completed.
-
CLINICAL_TRIALS trial_result · 2025-08-27Clinical Trial Update: Mycophenolate Mofetil in Patients With Progressive Idiopathic Membranous Nephropathy [Phase 3]
Phase 3 trial of mycophenolate mofetil in progressive idiopathic membranous nephropathy has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2025-03-25Clinical Trial Update: MOR202 for Refractory MN [Phase 2]
A Phase 2 clinical trial update on MOR202 for refractory membranous nephropathy, with the study status listed as completed.
-
CLINICAL_TRIALS trial_result · 2025-02-13Clinical Trial Update: Phase II Study Assessing Safety and Efficacy of APL-2 in Glomerulopathies [Phase 2]
Phase II trial of APL-2 in glomerulopathies completed; results have been posted.
-
CLINICAL_TRIALS trial_result · 2025-02-07Clinical Trial Update: Efficacy, Safety and PK/PD of MOR202 in Anti-PLA2R+ Membranous Nephropathy (aMN) (NewPLACE) [Phase 2]
Phase 2 results update reporting efficacy, safety and PK/PD of MOR202 in anti-PLA2R positive membranous nephropathy (NewPLACE).
-
CLINICAL_TRIALS trial_result · 2024-12-24Clinical Trial Update: Trial to Assess Safety and Efficacy of MOR202 in Anti-PLA2R + Membranous Nephropathy (aMN) [Phase 1, Phase 2]
This clinical trial update reports Phase 1/2 results for MOR202 in anti-PLA2R positive membranous nephropathy, with the study completed and …
-
CLINICAL_TRIALS trial_result · 2024-11-22Clinical Trial Update: A Study to Assess Effectiveness and Safety of Efgartigimod in Chinese Patients with Primary Membranous Nephropathy (ZL-1103-014) [Phase 2]
A Phase 2 trial evaluating efgartigimod in Chinese patients with primary membranous nephropathy was terminated.
-
CLINICAL_TRIALS trial_result · 2024-09-26Clinical Trial Update: The Efficacy and Safety of Treatment With Telitacicept in Primary Membranous Nephropathy [Phase 2]
This update covers a Phase 2 clinical trial evaluating the efficacy and safety of Telitacicept for primary membranous nephropathy, which is …
-
CLINICAL_TRIALS trial_result · 2024-06-13Clinical Trial Update: Clinical Trial of Anti-PLA2R-IgG Detection Kit (Time-resolved Fluorescence Immunoassay)
A completed clinical trial evaluating an Anti-PLA2R-IgG detection kit (time-resolved fluorescence immunoassay) for membranous nephropathy.
-
CLINICAL_TRIALS trial_result · 2024-05-07Clinical Trial Update: Rituximab, Cyclophosphamide, and Corticosteroids in Primary Membranous Nephropathy [NA]
A clinical trial evaluating Rituximab, Cyclophosphamide, and Corticosteroids for PLA2R-induced membranous nephropathy is currently recruitin…
-
CLINICAL_TRIALS trial_result · 2024-05-02Clinical Trial Update: Study to Evaluate the Safety, Tolerability of BCX9930 in Participants With Either Complement 3 Glomerulopathy (C3G), Immunoglobulin A Nephropathy (IgAN), or Primary Membranous Nephropathy (PMN) [Phase 2]
Phase 2 study evaluating safety and tolerability of BCX9930 in complement-mediated kidney diseases was terminated; results have been posted.
-
CLINICAL_TRIALS trial_result · 2024-04-02Clinical Trial Update: Clinical Study of Rituximab Combined With Corticosteroids or Rituximab Monotherapy in the Treatment of Primary Membranous Nephropathy [Phase 4]
Clinical trial update for a Phase 4 study evaluating rituximab with corticosteroids or rituximab monotherapy in primary membranous nephropat…
-
CLINICAL_TRIALS trial_result · 2023-09-05Clinical Trial Update: Evaluate the Efficacy and Safety of SHR1459 Tablets in Patients With Primary Membranous Nephropathy [Phase 2]
Phase 2 clinical trial update for SHR1459 tablets in patients with primary membranous nephropathy evaluating efficacy and safety.
-
CLINICAL_TRIALS trial_result · 2023-07-12Clinical Trial Update: Interferon Alfa Therapy Based on Th17 Profile in Membranous Nephropathy [Phase 2]
Phase 2 clinical trial evaluating interferon alfa therapy guided by Th17 profile for membranous nephropathy; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2022-08-15Clinical Trial Update: Adrenocorticotropic Hormone in Membranous Nephropathy [Phase 4]
A Phase 4 clinical trial evaluating adrenocorticotropic hormone in membranous nephropathy has completed with results posted in 2022.